NEUPATH HEALTH ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AS PART OF PLANNED TRANSITION, PRE-ANNOUNCES STRONG 2025 RESULTS

2026-01-26 - 12:44

TORONTO -- NeuPath Health Inc. (TSXV:NPTH) (NeuPath or the “Company”) today announced the timing and details for a planned leadership transition in 2026, as well as preliminary revenue and Adjusted EBITDA expectations for 2025. As part of its long-term succession planning, NeuPath’s President Stephen Lemieux will succeed Joseph Walewicz as Chief Executive Officer effective April 1, 2026. Joseph will continue his role on the Board of Directors and work closely with NeuPath’s leadership team to support NeuPath’s growth initiatives. The Company also announced the promotion of Sandee Dela Cruz to the new position of Chief Information Officer effective January 1, 2026. Read More